Adjuvant psychological therapy in long‐term endocrine conditions

Daniels, Jo; Turner‐Cobb, Julie M.

doi:10.1111/cen.13341

Cited by 7 publications

(4 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…With up to a third of RP episodes stress/anxiety related25 and the remainder associated with cold exposure, episodes are potentially preventable. Due to the pivotal role of psychological and physical stress as a trigger in RP, psychophysiology in RP appears to be important: the essential role of the limbic hypothalamic–pituitary–adrenal axis and neuroendocrine system in stress and physiological disregulation has been explored elsewhere in medical conditions complicated by anxiety,34–36 however, not within RP.…”

Section: Discussionmentioning

confidence: 99%

Behaviour change interventions for the management of Raynaud’s phenomenon: a systematic literature review

2018

Self Cite

View full text Add to dashboard Cite

ObjectivesRaynaud’s phenomenon (RP) is a significant cause of morbidity. Vasodilator medications cause unwanted adverse effects, with behavioural and lifestyle changes forming the mainstay of self-management; this is difficult to implement successfully. The objectives of this study were to evaluate the efficacy of behaviour change interventions for RP and identify learning points for future treatment development.DesignSystematic literature review and narrative synthesis of findings.Data sourcesEMBASE, MEDLINE, Cochrane and PsycINFO were searched for eligible studies on 22 August 2017.Eligibility criteriaRandomised controlled trials (RCTs) of behaviour change interventions with at least one control comparator arm.Data extraction and synthesisStudy selection, data extraction and risk of bias were assessed independently by two reviewers, reaching consensus with a third when necessary. Primary outcomes of interest included severity/impact, frequency and duration of RP episodes, pain, disability, adverse events and study withdrawal.ResultsOf 638 articles retrieved, eight studies fulfilled criteria for inclusion. Biofeedback was the active behaviour change treatment arm for seven studies, with one study reporting a behavioural intervention. Studies were published 1978–2002; six were USA-based studies, one German and one Swedish. Using Cochrane Risk of Bias assessment, studies were assessed to be overall at high risk of bias, with the exception of one large RCT. The total sample included 495 participants (study median=29), with a median age of 39.5 years and preponderance towards females (73%). Five studies reported significant effects in primary outcomes of interest; however, due to missing data, relative efficacy of interventions could not be reliably assessed.ConclusionsThere is no evidence to support or refute claims of the efficacy of behaviour change interventions for the management of RP. There remains a strong case for developing and testing behaviour change interventions that focus on self-management; however, theoretical development and advancement in trial quality is imperative to underpin future work.PROSPERO registration numberCRD42017049643.

show abstract

Section: Discussionmentioning

confidence: 99%

Behaviour change interventions for the management of Raynaud’s phenomenon: a systematic literature review

2018

Self Cite

View full text Add to dashboard Cite

show abstract

“…Chronic production of high levels of cortisol results in Cushing syndrome, also known as hypercortisolism ( 22 ), while insufficient amounts of adrenal hormones (cortisol, or cortisol and aldosterone) can lead to Addison's disease ( 23 ). Both of these conditions involve the dysfunction of HPA axis signaling and have been linked to immune, metabolic, cardiovascular, and mental conditions such as melancholic depression and chronic anxiety ( 24 , 25 ). Therefore, tight control of glucocorticoid secretion is critical to maintain homeostasis.…”

Section: Stress Hormone Signaling and Physiological Effectsmentioning

confidence: 99%

Predisposition of Women to Cardiovascular Diseases: A Side-Effect of Increased Glucocorticoid Signaling During the COVID-19 Pandemic?

Dhaibar

Cruz‐Topete

2021

Front. Glob. Womens Health

View full text Add to dashboard Cite

The novel coronavirus disease 2019 (COVID-19) pandemic has created a significant health crisis worldwide. To mitigate this disease's spread, “social distancing” and “shelter in place” have been implemented. While these actions have been critical to controlling the pandemic, they have short- and long-term mental health consequences due to increased stress. There is a strong association between mental stress and cardiovascular disease (CVD). Young women (pre-menopausal) are at high risk of developing CV events in response to mental stress compared to age-matched men. The mechanisms underlying women's increased reactivity and response to stress are mostly unknown. The present review summarizes the known physiological consequences of mental stress in women's CV health and the latest molecular findings of the actions of the primary stress hormones, glucocorticoids, on the CV system. The current data suggest a clear link between psychological stress and heart disease, and women have an increased sensitivity to the harmful effects of stress hormone signaling imbalances. Therefore, it is expected that with the given unprecedented levels of stress associated with the COVID-19 pandemic, women's CV health will be significantly compromised. It is critical to widen our understanding of the direct contribution of mental stress to CVD risk in women and to identify biochemical markers with predictive value for CVD in female patients with/without cardiovascular conditions who have experienced significant mental stress during the current pandemic.

show abstract

“…Based on the notion that thoughts, feelings, behaviour and physiology are interlinked, evidence supports use in similar conditions such as inflammatory arthritis (Marques et al ., 2021). Such an integrated approach has the potential to improve care by broadening intervention options and optimising efficacy of treatment (Daniels and Turner-Cobb, 2017).…”

Section: Introductionmentioning

confidence: 99%

Psychological factors in symptom severity and quality of life in Raynaud’s phenomenon

Irving,

Daniels

2024

Behav. Cogn. Psychother.

Self Cite

View full text Add to dashboard Cite

Background: Despite emotional stress being recognised as a key trigger for Raynaud’s phenomenon episodes, research in the area is still in its infancy. Aims: This study investigated the role of psychological factors relating to symptom severity and quality of life, and differences between Raynaud’s types (primary and secondary) to further inform the development of intervention in this field. Method: A cross-sectional design was used. Two hundred and ten adults with Raynaud’s completed an online questionnaire measuring stress, anxiety, depression, anxiety sensitivity, beliefs about emotions, symptom severity and quality of life. Results: Primary and secondary Raynaud’s groups differed in anxiety (p < .004), symptom severity (p < .001) and quality of life (p < .001). Stepwise multiple regressions indicated anxiety and Raynaud’s type explained 23% variance in hand symptom severity (p < .001); anxiety, Raynaud’s type and anxiety sensitivity explained 29% variance in symptom severity (global impact, p < .001); depression, Raynaud’s type and anxiety sensitivity explained 32% variance in quality of life (p < .001). Conclusions: Results highlight the importance of psychological factors in Raynaud’s phenomenon, indicating possible targets for treatment. Interventions such as cognitive behavioural therapy, which target both physical and psychological wellbeing, bear some promise as an adjuvant therapy for this group.

show abstract

Adjuvant psychological therapy in long‐term endocrine conditions

Cited by 7 publications

References 33 publications

Behaviour change interventions for the management of Raynaud’s phenomenon: a systematic literature review

Behaviour change interventions for the management of Raynaud’s phenomenon: a systematic literature review

Predisposition of Women to Cardiovascular Diseases: A Side-Effect of Increased Glucocorticoid Signaling During the COVID-19 Pandemic?

Psychological factors in symptom severity and quality of life in Raynaud’s phenomenon

Contact Info

Product

Resources

About